Antibody-based HIV-1 vaccines: recent developments and future directions.

Antibody-based HIV-1 vaccines: recent developments and future directions.

Bibliographic Details
Main Authors:	David Montefiori, Quentin Sattentau, Jorge Flores, José Esparza, John Mascola, Working Group convened by the Global HIV Vaccine Enterprise
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2007-12-01
Series:	PLoS Medicine
Online Access:	https://doi.org/10.1371/journal.pmed.0040348

Similar Items

The Global HIV/AIDS Vaccine Enterprise: scientific strategic plan.
by: Global HIV/AIDS Vaccine Enterprise
Published: (2005-02-01)

Improving defences at the portal of HIV entry: mucosal and innate immunity.
by: Robin J Shattock, et al.
Published: (2008-04-01)

HIV Vaccine: Recent Advances, Current Roadblocks, and Future Directions
by: Muni Rubens, et al.
Published: (2015-01-01)

Potential role for neutralizing antibodies in HIV-1 infection
by: J. Mascola
Published: (2015-12-01)

The cat and mouse of HIV-1 antibody escape.
by: John R Mascola
Published: (2009-09-01)

Macrophage Cell-Cell Interactions Promoting HIV-1 Infection
by: Maeva Dupont, et al.
Published: (2020-04-01)

Effect of HIV Envelope Vaccination on the Subsequent Antibody Response to HIV Infection
by: Zanele Ditse, et al.
Published: (2020-01-01)

Profiles of human serum antibody responses elicited by three leading HIV vaccines focusing on the induction of Env-specific antibodies.
by: Michael Vaine, et al.
Published: (2010-11-01)

DNA Vaccines: Recent Developments and the Future
by: Britta Wahren, et al.
Published: (2014-10-01)

Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humans
by: Kelly E. Seaton, et al.
Published: (2021-04-01)

Viral Determinants of HIV-1 Macrophage Tropism
by: Christopher J. A. Duncan, et al.
Published: (2011-11-01)

Antibody Conjugates-Recent Advances and Future Innovations
by: Donmienne Leung, et al.
Published: (2020-01-01)

Antibody-Mediated Fcγ Receptor-Based Mechanisms of HIV Inhibition: Recent Findings and New Vaccination Strategies
by: Christiane Moog, et al.
Published: (2009-12-01)

Which antibody functions are important for an HIV vaccine ?
by: Bin eSu, et al.
Published: (2014-06-01)

Neutralization-enhancing RF antibodies for HIV vaccines
by: Konstantin V Suslov
Published: (2014-12-01)

Complete functional mapping of infection- and vaccine-elicited antibodies against the fusion peptide of HIV.
by: Adam S Dingens, et al.
Published: (2018-07-01)

Vaccine Induction of Heterologous Tier 2 HIV-1 Neutralizing Antibodies in Animal Models
by: Kevin O. Saunders, et al.
Published: (2017-12-01)

Vaccine Innovation Conference 2017
by: Vaccine Industry Committee
Published: (2017-07-01)

A novel strategy for inducing enhanced mucosal HIV-1 antibody responses in an anti-inflammatory environment.
by: Frank Wegmann, et al.
Published: (2011-01-01)

Retroviruses and the Third Synapse
by: Quentin J. Sattentau
Published: (2010-04-01)

Cell-to-Cell Spread of Retroviruses
by: Quentin J. Sattentau
Published: (2010-06-01)

Comparative efficiency of HIV-1-infected T cell killing by NK cells, monocytes and neutrophils.
by: Adjoa Smalls-Mantey, et al.
Published: (2013-01-01)

Stepwise Conformational Stabilization of a HIV-1 Clade C Consensus Envelope Trimer Immunogen Impacts the Profile of Vaccine-Induced Antibody Responses
by: Alexandra Hauser, et al.
Published: (2021-07-01)

Advances in Antibody-Based HIV-1 Vaccines Development
by: Ursula Dietrich
Published: (2020-01-01)

Peptide-Based Vaccination for Antibody Responses Against HIV
by: Behazine Combadière, et al.
Published: (2019-09-01)

Nanoparticle Vaccines for Inducing HIV-1 Neutralizing Antibodies
by: Mitch Brinkkemper, et al.
Published: (2019-07-01)

Correction: HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies.
by: Celia C LaBranche, et al.
Published: (2019-03-01)

What Has 30 Years of HIV Vaccine Research Taught Us?
by: José Esparza
Published: (2013-10-01)

Virus-Like Particle Based Vaccines Elicit Neutralizing Antibodies against the HIV-1 Fusion Peptide
by: Alemu Tekewe Mogus, et al.
Published: (2020-12-01)

Hepatitis B vaccine antibody response and the risk of clinical AIDS or death.
by: Michael L Landrum, et al.
Published: (2012-01-01)

HIV transmitted/founder vaccines elicit autologous tier 2 neutralizing antibodies for the CD4 binding site.
by: Nathanael P McCurley, et al.
Published: (2017-01-01)

More surprises in the development of an HIV vaccine
by: Jose eEsparza, et al.
Published: (2014-07-01)

Cancer Vaccines for Genitourinary Tumors: Recent Progresses and Future Possibilities
by: Brigida Anna Maiorano, et al.
Published: (2021-06-01)

Anti-idiotypic antibodies as cancer vaccines: achievements and future improvements
by: Maha Zohra eLadjemi
Published: (2012-11-01)

HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers.
by: Silvia Capucci, et al.
Published: (2017-01-01)

Major Scientific Hurdles in HIV Vaccine Development: Historical Perspective and Future Directions
by: Tiza Ng’uni, et al.
Published: (2020-10-01)

HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies.
by: Celia C LaBranche, et al.
Published: (2018-11-01)

Analysis of V2 antibody responses induced in vaccinees in the ALVAC/AIDSVAX HIV-1 vaccine efficacy trial.
by: Susan Zolla-Pazner, et al.
Published: (2013-01-01)

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
by: Yousuf Ahmed, et al.
Published: (2017-09-01)

Antibodies in Vaccine Protection against SIV and HIV-1 Infection
by: Alpert, Michael
Published: (2012)